Labshake search
Citations for Stemcell Technologies :
1 - 50 of 213 citations for CD3 epsilon Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biophysics 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Immunology 2023Quote: ... Anti-CD3 biotin (STEMCELL Technologies) was also added at a concentration of 2.5 μL/mL to increase NK cell purity ...
-
bioRxiv - Molecular Biology 2022Quote: ... or CD3-CD28 ImmunoCult (StemCell Technologies). Aliquots of cell culture supernatants were taken at 7 days post challenge for measurement of cytokine secretion using Luminex multiplex assays as described below ...
-
bioRxiv - Immunology 2023Quote: ... Anti-CD3/CD28/CD2 Immunocult (Stemcell Technologies) was used for T-cell activation ...
-
bioRxiv - Immunology 2021Quote: ... cells were preactivated for 5 days with IL-2 and either 1:1 aAPCs or 25 μl/ml CD3/CD28/CD2 tetramer (ImmunoCult Human CD3/CD28/CD2 T Cell Activator, STEMCELL Technologies). L cells (ATCC CRL-2648 ...
-
bioRxiv - Immunology 2020Quote: ... Human T cells were also isolated from the thymus tissue in humanized SRG rats via immunomagnetic selection using anti-human CD3 antibody (EasySep™ Human CD3 Positive Selection, Catalog # 17951, Stemcell Technologies) and treated without (vehicle ...
-
bioRxiv - Immunology 2021Quote: ... CD3+ T cells were isolated by RosetteSep (STEMCELL Technologies).
-
bioRxiv - Immunology 2019Quote: ... and Immunocult anti-CD3/28 activator (Stemcell Technologies; 10971) for 4 days ...
-
bioRxiv - Immunology 2021Quote: ... CD3/CD28 tetrameric antibody complexes (ImmunoCult by STEMCELL Technologies), or a combination of plate-bound anti-CD3 (OKT3 ...
-
bioRxiv - Bioengineering 2023Quote: ... Human recombinant VEGF-165 (Stemcell technologies; Saint Egrève ...
-
bioRxiv - Microbiology 2020Quote: ... Immunocult human CD3/CD28 T cell activator (STEMCELL Technologies, USA) was used to stimulate the PBMCs as a positive control for immunological activation.
-
bioRxiv - Immunology 2023Quote: ... or ImmunoCult Human CD3/CD28 T cell activator (Stemcell Technologies) was added at a dilution of 1:500.
-
bioRxiv - Immunology 2022Quote: ... and 30 μl of additional biotinylated anti-CD3 (STEMCELL Technologies, 18051) was added to the sample to improve purity ...
-
bioRxiv - Genomics 2024Quote: CD3+ T cells were isolated from healthy donor leukopaks (Stemcell Technologies) using bead separation (Stemcell Technologies ...
-
bioRxiv - Genomics 2024Quote: ... CD3+ T cells were isolated by magnetic bead separation (StemCell Technology) from PBMCs of three leukopaks (Cambridge Biosciences ...
-
Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer CellsbioRxiv - Immunology 2023Quote: ... ImmunoCult™ human CD3/CD28/CD2 T-cell activator (StemCell Technologies) was used to activate isolated T cells in vitro for 2 days following the manufacturer’s recommendations.
-
bioRxiv - Molecular Biology 2019Quote: ... 6 ng/mL recombinant mouse IL3 and 10 ng/mL recombinant human IL-6 (all from Stem Cell Technologies). On Day 0 ...
-
bioRxiv - Neuroscience 2019Quote: ... ImmunoCult Human CD3/CD28 T cell Activator and 20ng rhIL2 (Stemcell Technologies) was added to culture medium ...
-
bioRxiv - Cancer Biology 2021Quote: ... Leukemic blasts were isolated from whole blood using CD3 depletion (StemCell Technologies) and ficoll density gradient separation (GE Healthcare) ...
-
bioRxiv - Cancer Biology 2021Quote: ... activated with CD3/CD28 T cell Activator reagent (STEMCELL Technologies, Vancouver, Canada) and transduced on day 1 with the CAR lentiviral particles in the presence of 1X Transdux (Systems Biosciences) ...
-
bioRxiv - Cancer Biology 2023Quote: PDECs were treated with 25ul/mL anti-CD3/CD28/CD2 (Stemcell Technologies), 100ug/mL Atezolizumab (Selleck Chemicals) ...
-
bioRxiv - Bioengineering 2023Quote: ... and ImmunoCult Human CD3/CD28 T Cell Activator (Stem Cell Technologies, 10971) was added at 5 μL/mL to a total volume to 200 μL ...
-
bioRxiv - Bioengineering 2024Quote: ... and ImmunoCult™ Human CD3/CD28 T Cell Activator (STEMCELL TECHNOLOGIES, #10971) for a duration of 3 days ...
-
bioRxiv - Cancer Biology 2021Quote: ... recombinant mouse Interleukin-3 (6 ng/ml) and recombinant human Interleukin-6 (10 ng/ml) (all from Stem Cell Technologies). 200ul fresh SFEM medium with cytokines was added on Day 5 and 8 and cells were counted on Day 5 and 10.
-
bioRxiv - Immunology 2022Quote: ... recombinant human FGF (25ug/mL; Stem Cell Technologies), and recombinant human EGF (10 ug/mL ...
-
bioRxiv - Immunology 2020Quote: ... Human Recombinant IFNγ (10ng/mL, StemCell Technologies 78020) was added to the media for a period of 60 minutes ...
-
bioRxiv - Immunology 2022Quote: ... recombinant human IL-12 (Stemcell Technologies, Vancouver, Canada), IL-15 (Miltenyi Biotec ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... recombinant EGF (20 ng/mL, human, STEMCELL Technologies) and antibiotic antimycotic solution (100x ...
-
bioRxiv - Cancer Biology 2023Quote: ... recombinant human Noggin (100 ng/ml, Stemcell Technologies), B-27 supplement (ThermoFisher) ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... recombinant bFGF (20 ng/mL, human, STEMCELL Technologies), recombinant EGF (20 ng/mL ...
-
bioRxiv - Cancer Biology 2024Quote: ... human recombinant bFGF (hrbFGF) (Stem Cell Technologies, 78003), and heparin (Stem Cell Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...
-
bioRxiv - Genomics 2022Quote: ... 1000 cells of each sorted population were seeded in 1 mL of methylcellulose medium supplemented with recombinant murine SCF and IL-3 with recombinant human IL-6 and Epo (M3434, STEMCELL Technologies) in duplicate ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). After sublethal conditioning of 9-12 weeks old Gaa−/− mice with 7.5 Gy gamma-irradiation (1.6 Gy/min ...
-
bioRxiv - Immunology 2019Quote: ... An ImmunoCult human CD3/CD28 T-cell activator (STEMCELL Technologies; cat. no. 10971) was used to activate positive control T cells according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2021Quote: ... and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies). T cells were cultured at 37°C ...
-
bioRxiv - Bioengineering 2021Quote: ... and 1.25% ImmunoCult Human CD3/CD28/CD2 T cell activator (STEMCELL Technologies, 10970). After 48 hours ...
-
bioRxiv - Immunology 2021Quote: ... and 25 μL/mL ImmunoCult Human CD3/CD28 T Cell Activator (STEMCELL Technologies). Cells were expanded in RPMI 1640 medium (Thermo Fisher Scientific ...
-
bioRxiv - Immunology 2021Quote: ... and 25 μL/mL ImmunoCult Human CD3/CD28 T Cell Activator (STEMCELL Technologies).
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... CD3-CD19- mononuclear cells were enriched by Lymphoprep (Stem Cell Technologies, Grenoble, France) density gradient centrifugation followed by Magnetic-activated cell sorting using biotin MicroBead kit (Miltenyi Biotec ...
-
bioRxiv - Cell Biology 2020Quote: ... and the following mouse monoclonal antibodies: anti-CD3 (Clone UCHT1, StemCell Technologies, #60011) and anti-Ku80 (BD Bioscience ...
-
bioRxiv - Microbiology 2023Quote: ... magnetically isolated rCD4 (CD3+/CD4+/CD69-/ CD25-/ HLA-DR-) T cells (Stemcell Technologies) were rested in the presence of antiretroviral drugs (10nM Raltegravir and 20nM Efavirenz) ...
-
bioRxiv - Genomics 2024Quote: ... 250 µL of ImmunoCult Human CD3/CD28 T Cell Activator Mix (StemCell Technology) was added to the cells and incubated at 37°C ...
-
bioRxiv - Cancer Biology 2020Quote: ... containing 100 ng/mL recombinant mouse SCF and 100ng/mL recombinant human TPO for a total of 7 days (all from Stem Cell Technologies).
-
bioRxiv - Molecular Biology 2021Quote: ... and human recombinant IL-2 (Stemcell Technologies, Vancouver, Canada). Activated CD4+ T cells were transfected with pVax-CasRx and gRNA plasmids by nucleofection using Lonza 4d nucleofector ...
-
bioRxiv - Cell Biology 2021Quote: ... 20 ng/ml human recombinant IL-6 (STEMCELL Technologies) and 10 ng/ml mouse recombinant IL-3 (R&D ...
-
bioRxiv - Cell Biology 2023Quote: ... and 1000 U recombinant human LIF (StemCell Technologies #78055). Medium was replaced daily ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant EGF (20 ng/mL, STEMCELL Technologies, #78006.2), human recombinant FGF (10 ng/mL ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant EGF (2 ng/mL, STEMCELL Technologies, #78006.2), antibiotic-antimycotic (1X ...